These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1704939)

  • 1. [Immunohistochemical studies on bladder tumours. Immunohistochemical evaluation on intravesical therapy for bladder tumours].
    Onodera Y
    Nihon Hinyokika Gakkai Zasshi; 1990 Nov; 81(11):1654-8. PubMed ID: 1704939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunohistochemical studies on bladder tumours. Evaluation by CEA, ferritin, beta 2-MG, keratin and glycogen].
    Onodera Y
    Nihon Hinyokika Gakkai Zasshi; 1990 Nov; 81(11):1649-53. PubMed ID: 1704938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathological characterization of a syngeneic orthotopic murine bladder cancer model.
    Chade DC; Andrade PM; Borra RC; Leite KR; Andrade E; Villanova FE; Srougi M
    Int Braz J Urol; 2008; 34(2):220-6; discussion 226-9. PubMed ID: 18462521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of thymidine phosphorylase is a prognostic predictor for the intravesical recurrence of superficial bladder cancer.
    Nonomura N; Nakai Y; Nakayama M; Inoue H; Nishimura K; Hatanaka E; Arima R; Kishimoto T; Miki T; Kuroda H; Okuyama A
    Int J Clin Oncol; 2006 Aug; 11(4):297-302. PubMed ID: 16937303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavior of epithelial differentiation antigens (carcinoembryonic antigen, epithelial membrane antigen, keratin and cytokeratin) in transitional cell carcinomas of the bladder.
    Sánchez-Fernández de Sevilla MC; Morell-Quadreny L; Gil-Salom M; Pérez-Bacete M; Fenollosa-Entrena B; Llombart-Bosch A
    Urol Int; 1992; 48(1):14-9. PubMed ID: 1376008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linitis plastica-like carcinoma of the urinary bladder.
    Azadeh B; Vijayan P; Chejfec G
    Br J Urol; 1989 May; 63(5):479-82. PubMed ID: 2471571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.
    Samaratunga H; Khoo K
    Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunohistochemical study of keratin, carcinoembryonic antigen, human chorionic gonadotropin and alpha-fetoprotein in lung cancer.
    Kimura N; Ghandur-Mnaymen L
    Tohoku J Exp Med; 1985 Jan; 145(1):23-38. PubMed ID: 2580364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Isoantigens ABH in bladder tumors as an indicator of malignant potential: a combined study with CEA, BMG, Leu-M1 and H-Ag].
    Saegusa M
    Hinyokika Kiyo; 1989 Aug; 35(8):1311-21. PubMed ID: 2683647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of formalin- and acetone-fixation for immunohistochemical detection of carcinoembryonic antigen (CEA) and keratin.
    Kaku T; Ekem JK; Lindayen C; Bailey DJ; Van Nostrand AW; Farber E
    Am J Clin Pathol; 1983 Dec; 80(6):806-15. PubMed ID: 6195915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intravesical instillation of antitumor drugs in the development of N-butyl-N-(4-hydroxybutyl) nitrosamine-induced bladder tumors in rats.
    Suzuki T; Imai K; Takezawa Y; Tsuji H; Yamanaka H; Suzuki K
    Hinyokika Kiyo; 1989 Feb; 35(2):247-51. PubMed ID: 2735235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanism of intravesical instillation of pirarubicin for preventing recurrence of non-muscle invasive bladder cancer].
    Li Q; Xu T; Wang XF
    Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):904-7. PubMed ID: 20193328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keratin, luminal epithelial antigen and carcinoembryonic antigen in human urinary bladder carcinomas. An immunohistochemical study.
    Nathrath WB; Arnholdt H; Wilson PD
    Pathol Res Pract; 1982; 175(2-3):299-307. PubMed ID: 6190152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach.
    Lagendijk JH; Mullink H; van Diest PJ; Meijer GA; Meijer CJ
    J Clin Pathol; 1999 Apr; 52(4):283-90. PubMed ID: 10474521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A randomized study of pirarubicin (THP) versus adriamycin (ADM) for intravesical instillation therapy against superficial bladder cancer].
    Kawamura J; Tochigi H; Obata K; Ueda K; Otaguro K; Kuriyama M; Shinoda M; Naruse K; Murase T; Hasegawa Y
    Hinyokika Kiyo; 1992 Mar; 38(3):379-85. PubMed ID: 1523998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of intravesical instillation therapy of superficial bladder tumor--combination therapy of mitomycin C, adriamycin, peplomycin and cytosine arabinoside].
    Kinoshita N; Tochigi H; Yanagawa M; Yamakawa K; Sakurai M; Hioki T; Kawamura J
    Hinyokika Kiyo; 1990 Mar; 36(3):257-63. PubMed ID: 1693807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prophylactic intravesical instillation therapy in patients with superficial bladder cancer--results of a randomized prospective study].
    Tsushima T; Nasu Y; Abeki N; Noda M; Saika T; Ohmori H; Kobashi K; Ozaki Y; Matsumura Y; Tanahashi T
    Nihon Hinyokika Gakkai Zasshi; 1992 Aug; 83(8):1314-21. PubMed ID: 1405170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravesical therapy with adriamycin plus verapamil in patients with superficial bladder cancer: a pilot study.
    Naito S; Kimiya K; Ueda T; Kumazawa J; Omoto T; Osada Y; Iguchi A; Ariyoshi A; Sagiyama K
    Urol Int; 1992; 48(3):270-3. PubMed ID: 1589915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunohistochemical determination of antigen 19-9 (CA 19-9) in transitional carcinoma of the bladder].
    Casetta G; Cavallini A; Piana P; Squintone L; Vottero M; Tizzani A
    Minerva Urol Nefrol; 1992; 44(3):169-72. PubMed ID: 1492266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of serum ferritin, CEA, beta 2-MG and PAP determinations in patients with urinary tract malignancies].
    Ohashi T; Tohjoh S; Takeda K; Kumon H; Morioka M; Matsumura Y; Ohmori H; Suyama B; Hironaka K
    Hinyokika Kiyo; 1983 Feb; 29(2):141-53. PubMed ID: 6375313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.